| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.02 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.03 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.077 | 0.03 |